Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease

被引：0
作者：
Phuc N. H. Trinh
Jo-Anne Baltos
Shane D. Hellyer
Lauren T. May
Karen J. Gregory
机构：
[1] Monash University,Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
[2] Monash University,Department of Pharmacology
[3] Monash Institute of Pharmaceutical Sciences,ARC Centre for Cryo
来源：
Purinergic Signalling | 2022年 / 18卷 / 4期
关键词：
D O I：
10.1007/s11302-022-09906-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：407 / 407
相关论文
共 50 条
[21]   Astroglial calcium signalling in Alzheimer's disease [J].
Verkhratsky, Alexei ;
Rodriguez-Arellano, J. J. ;
Parpura, Vladimir ;
Zorec, Robert .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) :1005-1012
[22]   Mitochondrial oxidant signalling in Alzheimer's disease [J].
Vina, Jose ;
Lloret, Ana ;
Valles, Soraya L. ;
Borras, Consuelo ;
Badia, Mari-Carmen ;
Pallardo, Federico V. ;
Sastre, Juan ;
Alonso, Maria-Dolores .
JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (02) :175-181
[23]   Oxidative stress signalling in Alzheimer's disease [J].
Zhu, XW ;
Raina, AK ;
Lee, HG ;
Casadesus, G ;
Smith, MA ;
Perry, G .
BRAIN RESEARCH, 2004, 1000 (1-2) :32-39
[24]   Chaperone signalling complexes in Alzheimer's disease [J].
Koren, John, III ;
Jinwal, Umesh K. ;
Lee, Daniel C. ;
Jones, Jeffrey R. ;
Shults, Cody L. ;
Johnson, Amelia G. ;
Anderson, Laura J. ;
Dickey, Chad A. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (04) :619-630
[25]   Intracellular calcium signalling in Alzheimer's disease [J].
Hermes, Marina ;
Eichhoff, Gerhard ;
Garaschuk, Olga .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) :30-41
[26]   Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? [J].
Merighi, Stefania ;
Travagli, Alessia ;
Nigro, Manuela ;
Pasquini, Silvia ;
Cappello, Martina ;
Contri, Chiara ;
Varani, Katia ;
Vincenzi, Fabrizio ;
Borea, Pier Andrea ;
Gessi, Stefania .
BIOMOLECULES, 2023, 13 (06)
[27]   Amyloid and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A() receptor [J].
Liu, Zhenhua ;
Wang, Fumin ;
Tang, Minglu ;
Zhao, Yongjun ;
Wang, Xiaoting .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) :435-442
[28]   Publisher Correction to: Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease [J].
Jinhua Wen ;
Menghua Zhao ;
Wenxiong Sun ;
Xiaohua Cheng ;
Luyi Yu ;
Duanwen Cao ;
Pu Li .
BMC Neuroscience, 22
[29]   Publisher Correction: The adenosine pathway in immuno-oncology [J].
Bertrand Allard ;
David Allard ;
Laurence Buisseret ;
John Stagg .
Nature Reviews Clinical Oncology, 2020, 17 (10) :650-650
[30]   An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? [J].
Merighi, Stefania ;
Poloni, Tino Emanuele ;
Pelloni, Lucia ;
Pasquini, Silvia ;
Varani, Katia ;
Vincenzi, Fabrizio ;
Borea, Pier Andrea ;
Gessi, Stefania .
FRONTIERS IN PHARMACOLOGY, 2021, 12
12345